Document is current
Any future updates will be listed below
-
Authors
Grieco, Domenico Luca
Jaber, Samir
Zakynthinos, Spyros
Demoule, Alexandre
Ricard, Jean-Damien
Navalesi, Paolo
Vaschetto, Rosanna
Hraiech, Sami
Klouche, Kada
Frat, Jean Pierre
Lemiale, Virginie
Fanelli, Vito
Chanques, Gerald
Longhini, Federico
Mancebo, Jordi
Gualano, Maria Rosaria
Ferreyro, Bruno L.
Brochard, Laurent J.
Antonelli, Massimo
Maggiore, Salvatore Maurizio
,
Natalini, Daniele
Ischaki, Eleni
Reuter, Danielle
Morán, Indalecio
La Combe, Béatrice
De Gaetano, Andrea
Ranieri, V. Marco
Aarab, Yassir
Azoulay, Elie
Belafia, Fouad
Berquier, Guillaume
Conseil, Matthieu
Costamagna, Andrea
Dangers, Laurence
De Jong, Audrey
Delemazure, Julie
Della Corte, Francesco
Gaudry, Stèphane
Grossi, Francesca
Iovino, Giovanni Carmine
Jean-Baptiste, Sylvain
Laissi, Mohammed
Larcher, Romaric
Le Meur, Matthieu
Leclaire, Clèment
Lopez, Paula Andrea
Malachias, Sotirios M.
Matteo, Marilena
Mayaux, Julienne
Messika, Jonathan
Monet, Clement
Morawiec, Elise
Papazian, Laurent
Parrilla, Francisco
Platon, Laura
Roux, Damien
Santantonio, Maria Teresa
Suarez, Juan Carlos
Tanzarella, Eloisa Sofia
Toni, Flavia
Menga, Luca Salvatore
-
Funding
Funding for this research was provided by:
Fisher and Paykel (Unrestricted research grant)
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 27 September 2025
First Online: 4 November 2025
Declarations
:
: The institutional review board of the coordinator center (Catholic University of The Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy) reviewed and approved the study protocol before trial initiation (n. 12634/13 on December 5th, 2013). By in-site beginning of enrolment, each local ethics committee reviewed and approved the study protocol. All enrolled patients provided written informed consent in accordance with committee recommendations.
: Not applicable.
: DLG has received payments for travel expenses by Getinge, Draeger and Hamilton, research grants by Fisher and Paykel and GE, and non-financial support for research by Intersurgical, Dimar and Harol. SJ reports receiving consulting fees from Draeger, Medtronic, Baxter, Fresenius-Xenios, and Fisher & Paykel. A Demoule reports grants from the French Ministry of Health, Lungpacer, Respinor, Liberate Medical, consulting fees from Respinor, Liberate Medical, SAT Lutech, payment or honoraria for lectures, presentations from Fisher & Paykel, Astra, support for attending meetings and/or travel from Respinor, outside the submitted work JDR reports consulting fees, covering of travel expenses and equipment support by Fisher & Paykel. PN research laboratory has received equipment and grants from Draeger, Gilead and Intersurgical S.p.A. He also received honoraria/speaking fees from Gilead, GSK, Shionogi, Getinge, Mindray. He contributed to the development of the helmet Next, whose license for patent belongs to Intersurgical S.P.A. and receives royalties for that invention. SH reports speaking fees by MSD, Shionogi, Advanz Pharma Biomerieux. JPF reports having received grants from the French Ministry of Health, outside the submitted work; grants, personal fees and non-financial support from Fisher & Paykel HealthCare, outside the submitted work; personal fees and non-financial support from SOS Oxygène, outside the submitted work. VL belongs to a research group which received fees from Gilead, Pfizer, Alexion, Sanofi, MSD and personal fees and covering for travel expenses by Biomerieux. LB’S laboratory has received support for research by Covidien (PAV), Air Liquide (CPR), Philips (equipment for sleep), Fisher & Paykel (high flow therapy) and GE healthcare. MA has received payments for Board participation from Menarini, and Shionogi, and a research grant by General Electric Healthcare. And Fisher & Paykel SMM discloses having received speaking fees by GE Healthcare, Masimo, Getinge and Aspen, fees for advisory board participation by Sanofi, and a research grant, support for travel expenses and receipt of materials by Fisher and Paykel.
